# Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

> **NCT01858662** · PHASE2 · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 4 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **PROCEDURE:** Metastases Resection ( multiple steep surgery possible)
- **DRUG:** 5-Fluorouracile
- **DRUG:** leucovorin L
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT01858662
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** due to poor recrutment
- **Last updated:** 2016-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858662, "Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01858662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*